ArticleInflammation2025
Inflammation and Hemoglobin Oxygen Affinity.
Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In septic patients, oxygen delivery is often impaired, yet the specific impact of inflammation on erythrocyte oxygen transport characteristics remains largely unexplored. This study examined the direct effects of endotoxin-induced inflammation on the oxygen dissociation curve (ODC) and evaluated dexamethasone and noradrenaline as potential pharmacological interventions to modulate hemoglobin oxygen-binding properties during inflammation. Blood samples from ten healthy male volunteers were allocated to four groups: control, lipopolysaccharide (LPS), LPS with dexamethasone, and LPS with noradrenaline. Samples were incubated at 37 °C for two hours. ODCs were determined, providing p50 values and Hill coefficients. Blood gas analysis, 2,3-bisphosphoglycerate levels, and interleukin-6 (IL-6) levels were measured to assess metabolic parameters and inflammatory response. p50 values and Hill coefficients showed no significant differences between LPS-stimulated samples and controls. LPS effectively induced inflammatory activation with significantly elevated IL-6 levels (1416 (1226–1778) vs. 3 [2–4] ng/l, p = 0.002). Dexamethasone co-treatment significantly increased p50 values compared to LPS alone (29.2 (28.1–29.7) vs. 26.9 (25.7–27.9) mmHg, p = 0.030) and altered Hill coefficients (2.47 (2.32–2.56) vs. 2.65 (2.57–2.86), p = 0.002), indicating a rightward shift of the ODC. Noradrenaline demonstrated anti-inflammatory effects with reduced IL-6 levels (1212 (1068–1427) vs. 1416 (1226–1778) ng/l, p = 0.013) but did not significantly alter oxygen-binding properties. Acute inflammation does not directly alter hemoglobin oxygen-binding properties. The novel dexamethasone-induced rightward shift of the ODC may facilitate oxygen release to tissues and could have important clinical implications for steroid therapy in septic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.